These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10232930)

  • 81. Effect of administration route and length of exposure on pharmacokinetics and metabolism of diltiazem in dogs.
    Yeung PK; Feng JD; Buckley SJ
    Drug Metabol Drug Interact; 2001; 18(3-4):251-62. PubMed ID: 11791888
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The pharmacokinetics and absolute bioavailability of selegiline in the dog.
    Mahmood I; Peters DK; Mason WD
    Biopharm Drug Dispos; 1994 Nov; 15(8):653-64. PubMed ID: 7888597
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Pharmacokinetics and bioavailability of etintidine in beagle dogs: effects of routes of administration, doses, dosage forms, and chronic dosing.
    Huang SM; Abrams LS; Marriott TB; Weintraub HS
    Biopharm Drug Dispos; 1988; 9(1):71-83. PubMed ID: 3342286
    [TBL] [Abstract][Full Text] [Related]  

  • 84. ALA-induced fluorescence in the canine oral cavity.
    Vaidyanathan V; Wiggs R; Stohl J; Baxi M
    Photomed Laser Surg; 2006 Jun; 24(3):383-8. PubMed ID: 16875448
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Pharmacodynamics of acute intranasal administration of verapamil: comparison with i.v. and oral administration.
    Arnold TH; Tackett RL; Vallner JJ
    Biopharm Drug Dispos; 1985; 6(4):447-54. PubMed ID: 4084670
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Pharmacokinetics of ambenonium chloride in dogs after intravenous and oral administration.
    Tharasse-Bloch C; Chabenat C; Boucly P; Boismare F; Marchand J
    Arzneimittelforschung; 1989 Feb; 39(2):257-8. PubMed ID: 2730696
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Pharmacokinetics of cyanamide in dog and rat.
    Obach R; Colom H; Arso J; Peraire C; Pruñonosa J
    J Pharm Pharmacol; 1989 Sep; 41(9):624-7. PubMed ID: 2573707
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The pharmacokinetics of HI-6 in beagle dogs.
    Simons KJ; Briggs CJ
    Biopharm Drug Dispos; 1983; 4(4):375-88. PubMed ID: 6661515
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Pharmacokinetics of enflicoxib in dogs: Effects of prandial state and repeated administration.
    Homedes J; Salichs M; Solà J; Menargues A; Cendrós JM; Encina G
    J Vet Pharmacol Ther; 2021 Nov; 44(6):888-901. PubMed ID: 34160092
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Degradation mechanism and stability of 5-aminolevulinic acid.
    Bunke A; Zerbe O; Schmid H; Burmeister G; Merkle HP; Gander B
    J Pharm Sci; 2000 Oct; 89(10):1335-41. PubMed ID: 10980508
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Stability and pharmacokinetics of flumazenil in the rat.
    Mandema JW; Gubbens-Stibbe JM; Danhof M
    Psychopharmacology (Berl); 1991; 103(3):384-7. PubMed ID: 2057540
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Pharmacokinetics and oral bioavailability of hydrocortisone.
    Derendorf H; Möllmann H; Barth J; Möllmann C; Tunn S; Krieg M
    J Clin Pharmacol; 1991 May; 31(5):473-6. PubMed ID: 2050835
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The pharmacokinetics of topotecan and its carboxylate form following separate intravenous administration to the dog.
    Davies BE; Minthorn EA; Dennis MJ; Rosing H; Beijnen JH
    Pharm Res; 1997 Oct; 14(10):1461-5. PubMed ID: 9358562
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Oral absorption and disposition kinetics of lidocaine hydrochloride in dogs.
    Boyes RN; Adams HJ; Duce BR
    J Pharmacol Exp Ther; 1970 Jul; 174(1):1-8. PubMed ID: 5424701
    [No Abstract]   [Full Text] [Related]  

  • 95. Pharmacokinetics of a valpromide isomer, valnoctamide, in dogs.
    Haj-Yehia A; Bialer M
    J Pharm Sci; 1988 Oct; 77(10):831-4. PubMed ID: 3148708
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Distribution and pharmacokinetics of fosfosal (UR-1521)].
    Rimbau V; López R; Fernández A; Forn J
    Arch Farmacol Toxicol; 1981 Apr; 7(1):61-4. PubMed ID: 7325717
    [No Abstract]   [Full Text] [Related]  

  • 97. Pharmacokinetics and pharmacodynamics of L-703,014, a potent fibrinogen receptor antagonist, after intravenous and oral administration in the dog.
    Barrett JS; Gould RJ; Ellis JD; Holahan MM; Stranieri MT; Lynch JJ; Hartman GD; Ihle N; Duggan M; Moreno OA
    Pharm Res; 1994 Mar; 11(3):426-31. PubMed ID: 8008711
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Des-enkephalin-gamma-endorphin (DE gamma E): pharmacokinetics in dogs after intravenous and subcutaneous administration.
    Verhoef J; van den Wildenberg HM
    Eur J Drug Metab Pharmacokinet; 1989; 14(3):229-34. PubMed ID: 2533073
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Pharmacokinetics of chlorpromazine in normal volunteers.
    Loo JC; Midha KK; McGilveray IJ
    Commun Psychopharmacol; 1980; 4(2):121-9. PubMed ID: 7428333
    [No Abstract]   [Full Text] [Related]  

  • 100. The use of isotopes in the determination of absolute bioavailability of drugs in humans.
    Lappin G; Rowland M; Garner RC
    Expert Opin Drug Metab Toxicol; 2006 Jun; 2(3):419-27. PubMed ID: 16863443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.